Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Roy Davis, Peter Maag


Nanosphere has appointed Roy Davis to its board of directors. Davis worked for Johnson & Johnson for nearly three decades before he retired this January. Davis was president of J&J Development Corporation and VP of corporate development for the whole company.

XDx has named Peter Maag to be its president and CEO, effective immediately. Maag previously was president of Novartis Diagnostics, where he ran the company's blood screening business and created a strategy for the company's investment into developing diagnostics for transplantation, infectious disease, and prenatal care. He also was country president for Novartis Pharma in Germany and held other positions at Novartis after working at McKinsey and Company.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.